-
10 May 2018
10 May 2018: Support for clinical trials traverses portfolios of ‘Industry, Innovation and Science’ and ‘Health’ and their initiatives such as the Biomedical Translation Fund, the Medical Research Future Fund and strategies to make Australia a preferred destination for clinical trials.
Read More
-
9 May 2018
8 May 2018: Federal Budget 2018/19 - Canberra, Australia – Tonight’s Federal Budget has revealed a comprehensive plan for “better targeting the research and development tax incentive” (R&DTI).
Read More
-
11 May 2017
MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has welcomed this year’s Budget, stating it is well positioned to provide major new investments in manufacturing industries and cutting edge research infrastructure.
Read More
-
9 May 2017
A decision regarding the R&D Tax Incentive looms tonight, as the Australian biotech industry awaits the Government’s response to the ‘Ferris, Finkel, Fraser’ Review of the R&D Tax Incentive, which is expected to be included in the 2017-18 Federal Budget.
Read More
-
5 May 2016
This week's Federal Budget revealed a welcome response to the Review of Medicines and Medical Devices Regulation, that will provide industry with savings of around $75 million per annum, by reducing red tape and regulation on the pharmaceutical and medical device industries.
Read More
-
14 May 2015
On the back of last year's savage Budget cuts to industry support and science programs, the biotech industry can be relieved it was not again targeted for direct savings. However, nor does this year’s Federal Budget offer excitement for the industry in terms of innovation stimulus.
Read More
